| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:1759.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Ischemic Mitral Regurgitation
Long-Term Outcome and Prognostic Implications With Quantitative Doppler Assessment
From the Division of Cardiovascular Diseases and Internal Medicine (F.G., M.E.-S., A.J.T.), the Division of Cardiovascular Surgery (K.J.Z.), and the Section of Biostatistics (K.R.B.), Mayo Clinic, Rochester, Minn.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Myocardial infarction (MI) can directly cause ischemic mitral regurgitation (IMR), which has been touted as an indicator of poor prognosis in acute and early phases after MI. However, in the chronic post-MI phase, prognostic implications of IMR presence and degree are poorly defined.
Methods and Results—We
analyzed 303 patients with previous (>16 days) Q-wave MI by ECG who
underwent transthoracic echocardiography: 194 with IMR quantitatively
assessed in routine practice and 109 without IMR matched for baseline
age (71±11 versus 70±9 years,
P=0.20), sex, and ejection
fraction (EF, 33±14% versus 34±11%,
P=0.14). In IMR patients,
regurgitant volume (RVol) and effective regurgitant orifice (ERO) area
were 36±24 mL/beat and 21±12 mm2,
respectively. After 5 years, total mortality and cardiac mortality for
patients with IMR (62±5% and 50±6%, respectively) were higher than
for those without IMR (39±6% and 30±5%, respectively) (both
P<0.001). In multivariate
analysis, independently of all baseline characteristics, particularly
age and EF, the adjusted relative risks of total and cardiac mortality
associated with the presence of IMR (1.88,
P=0.003 and 1.83,
P=0.014, respectively) and
quantified degree of IMR defined by RVol 
30 mL (2.05,
P=0.002 and 2.01,
P=0.009) and by ERO 20
mm2 (2.23,
P=0.003 and 2.38,
P=0.004) were
high.
Conclusions—In the chronic phase after MI, IMR presence is associated with excess mortality independently of baseline characteristics and degree of ventricular dysfunction. The mortality risk is related directly to the degree of IMR as defined by ERO and RVol. Therefore, IMR detection and quantification provide major information for risk stratification and clinical decision making in the chronic post-MI phase.
Key Words: infarction • mitral valve • prognosis • regurgitation
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Ischemic mitral regurgitation (IMR) is mitral regurgitation (MR) due to complications of coronary artery disease, in particular, myocardial infarction (MI), and not the fortuitous association of coronary artery disease with intrinsic valve disease such as rheumatic disease. In the acute phase of MI, IMR is frequent1 and appears to carry an adverse prognosis.1 2 3 However, the prognostic implications of IMR in the chronic post-MI phase are uncertain. In pioneering series that underscored the potential importance of IMR, patients were often included early after MI,4 and decreased survival of patients with IMR may have been due to inclusion of acute MI.2 3 Furthermore, MR angiographic grade was not independently predictive of survival, and only a score combining MR grade with clinical data was a weak independent predictor of outcome.4 Therefore, the SAVE (Survival And Ventricular Enlargement) study data proved of major interest by suggesting that mild IMR was associated with high mortality.5 However, because the study design excluded MR grade 3 or 4 and limited inclusion to 16 days after MI, the prognostic implications of IMR remain uncertain, particularly regarding specific implications of the full range of chronic IMR. Nevertheless, these pioneering series had the undisputed merit of raising the hypothesis that IMR, which affects 19% of patients after MI,4 5 may be a marker of poor outcome, suggesting that if observed in pure, chronic, definite IMR of all degrees, such an observation may have major prognostic and therapeutic implications.
For diagnosing IMR, murmur is of limited value,6 and objective methods are required. Angiography has been widely used4 5 but may imply referral based on severity of presentation; in addition, it has technical limitations and cannot define valvular anatomy and cause of MR. Echocardiography is highly accurate for anatomy, but standard color flow imaging is fraught with errors in IMR.7 However, quantitative Doppler methods have been developed8 9 10 11 that allow quantitative grading of MR in routine clinical practice.12
Hence, our aim was to analyze, in the post-MI chronic phase, the independent prognostic implications of IMR presence and degree, quantitatively assessed by Doppler echocardiography in routine practice.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Eligibility Criteria
Inclusion criteria were, first, presence of Q-wave MI on ECG, with history of MI older than 16 days before baseline assessment. The 16-day criterion was based on the SAVE study report of prognostic effect of IMR diagnosed within and not beyond 16 days after MI.5 Second, these patients underwent transthoracic echocardiography during the same clinical evaluation in routine practice from 1990 through 1997, showing either IMR, which was quantitatively assessed, or no MR. Exclusion criteria were recent MI (
16 days), previous cardiac surgery, papillary muscle
rupture, MR due to primary organic valve disease, or associated aortic
valve or congenital heart disease. Diagnosis of IMR was based on normal
leaflets with enlarged annulus and was easily differentiated from
organic MR, such as rheumatic disease or
prolapse.
Matching Process
Patients were all post-MI and satisfied all
eligibility criteria. Patients without MR were matched to those with MR
for age, sex, and left ventricular (LV) ejection fraction (EF) to
ensure baseline comparability of these major determinants of outcome.
The matching process was computerized, blinded, and performed before
any outcome information was obtained.
Follow-up was achieved for 294 patients (97%) up to 1999 or
death. Medications used during follow-up were recorded if prescribed
for 3 months. Comorbid diseases were summated as a comorbidity
index.
Echocardiographic Methods
LV and left atrial (LA) dimensions were obtained by
M-mode echocardiography, guided by 2D imaging. EF was visually
estimated13 in all patients
and combined with calculated
values14 in 205 (68%) and
used unaltered from original echocardiographic report via electronic
transfer. This method has high prognostic value in our
laboratory.15 Color flow
imaging was used to determine presence or absence of MR, but in all
patients with MR, degree of MR was graded with quantitative
measurements using at least 1 of the following 2 quantitative methods,
and final results were averages of measured
values:
- Quantitative
Doppler8 9 —Mitral
and aortic stroke volumes were calculated, and regurgitant volume
(RVol) was the difference between these 2 stroke volumes. The effective
regurgitant orifice (ERO) area was the ratio of RVol to regurgitant
time velocity integral (RTVI).16
- Proximal isovelocity surface area (PISA)
analyzed the proximal flow convergence, and ERO was the ratio of
regurgitant flow to regurgitant velocity.10 11
RVol was the product of ERO by RTVI.
Statistical Analysis
Continuous variables are expressed as mean±SD. Group
comparisons used t test or
2 test, as appropriate. Event rates after
diagnosis were estimated by Kaplan-Meier method. Analysis was performed
by censoring follow-up at time of cardiac surgery if eventually
performed (n=45). End points were overall survival and cardiac
mortality. IMR impact on outcome was analyzed in 2 ways, with presence
of IMR at baseline used as the categorical determinant of survival or
with quantified degree of IMR (RVol and ERO) used as continuous
variables. Risk ratios (RRs) associated with previously determined
thresholds12 were defined.
Other baseline predictors of survival were identified by Cox
proportional hazards analysis. Variables with
P<0.10 were tested in
multivariate modeling, and presence and quantitative degree of IMR were
added in final models.
We observed previously that EF decreases by 4% after surgical correction of IMR. To examine the hypothesis that EF is overestimated in patients with IMR, we analyzed the effect of IMR on mortality with EF of patients in whom IMR decreased by 4 points and that of patients with no change in IMR. This analysis was also repeated with EF of patients in whom IMR decreased by 8 and 10 points. P<0.05 was considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Baseline Characteristics
Eligibility criteria were fulfilled by 303 patients evaluated in the chronic post-MI stage: 109 without MR and 194 with IMR quantitatively assessed in routine practice. The degree of MR was determined by quantitative Doppler in 30 patients, by the PISA method in 146, and by both techniques in 18. Diagnosis of previous MI was confirmed by electrocardiography in all 303 patients (100%). Echocardiography detected regional wall motion abnormalities in 301 patients (99%) (single territory in 173 [57%], multiple territories in 128 [42%] with scar in 49 [16%] patients). Nuclear perfusion studies were available for 125 patients (41%) and indicated previous MI in 117 (94%). Of 185 patients who ultimately underwent coronary angiography, all had stenoses
70%, and only 83 (45%) had
single-vessel disease, with no significantly different distribution
between patients with and without IMR
(P=0.08). Baseline
characteristics of patients with and without IMR are compared in
Table 1
. Most risk factors were similar for the 2 groups.
Despite identical age and EF, patients with IMR had more symptoms, more
atrial fibrillation, more LV and LA enlargement, lower blood pressure,
and shorter deceleration time. Mean time between MI and index
echocardiogram was 86±90 months, similar for patients with and without
IMR (P=0.17), and MI was less
often anterior with IMR.
|
Impact of MR on Overall Survival
During total conservative follow-up of 817
patient-years, 118 deaths occurred.
IMR Presence
Patients with IMR experienced higher long-term
mortality rates than those without MR (62±5% versus 39±6% at 5
years, P0.001; univariate RR
[95% CI], 2.32 [1.56 to 3.52])
(Figure 1).
|
In multivariate analysis, independent baseline predictors of
overall survival were age
(P<0.001), EF
(P=0.008), New York Heart
Association (NYHA) class III or IV
(P=0.003), diabetes
(P=0.044), atrial fibrillation
(P=0.023), and
1/creatinine (P=0.006).
When IMR presence was added into the model, it negatively and
independently influenced outcome, with adjusted RR of 1.88
(Table 2).
|
Notably, IMR remained independently predictive of survival, adjusting for diastolic dysfunction (mitral deceleration time) (P=0.027), comorbidity index (P=0.0026), extent of coronary disease on coronary angiography (P=0.016), and for all variables showing baseline differences between patients with and without IMR (all P<0.003). The assumption that patients with IMR had a "true" EF decreased by 4%, 8%, or even 10% did not eliminate the IMR effect on overall mortality. Adjusted RRs associated with IMR presence under these assumptions were, respectively, 1.79, 1.66, and 1.60, with probability values of 0.008, 0.039, and 0.049.
IMR Degree
The RVol and ERO in IMR patients were 36±24 mL/beat
and 21±12 mm2, respectively. Patients with
RVol 30 mL demonstrated higher mortality than those with RVol <30 mL
(65±7% versus 56±9% at 5 years,
P<0.001, RR=1.13 per 10-mL
RVol increase)
(Figure 2). Patients with ERO 20
mm2 displayed higher 5-year mortality than
those with ERO <20 mm2 (71±9% versus
53±8%, P<0.001, RR=1.40 per
10-mm2 ERO increase)
(Figure 3). Adjusted for independent predictors of mortality,
RVol and ERO independently and unfavorably influenced mortality
(Tables 3 and 4).
|
|
|
|
In analysis limited to patients with MR, ERO remained
independently predictive of survival, with similar RR (1.33 per
10-mm2 increase,
P<0.001). Adjusted for extent
of coronary disease by coronary angiography, ERO remained independently
predictive of survival, with similar RR (1.37 per
10-mm2 increase,
P<0.001). In models including
classic clinical or echocardiographic signs of MR, ERO and RVol
remained significantly predictive of excess mortality (all
P<0.05), and no additional
significant predictor of survival was noted. When EF in IMR was
decreased by 4%, 8%, or 10%, the adjusted RRs associated with ERO
20 mm2 were, respectively, 2.01, 1.81, and
1.72 (P=0.014, 0.046, and
0.077). In multivariate models with both ERO and RVol, ERO remained
independently determinant of excess mortality (P=0.017), but RVol tended to be less significant (P=0.13).
Subgroup Analysis
Excess mortality with IMR presence remained
significant when analysis was restricted to males
(P<0.001) or females
(P=0.071), to patients younger
(P=0.010) or older
(P=0.005) than 75 years, and to
patients in sinus rhythm
(P=0.002), with diabetes
(P=0.041) or without diabetes
(P<0.001), and with mitral
valve deceleration time shorter
(P=0.064) or longer
(P=0.064) than 170 ms. IMR was
associated with excess mortality with EF 40% (RR=4.40,
P<0.001) or <40% (RR=1.84,
P=0.0065) even after adjustment
for age, sex, EF, and NYHA class
(P=0.0036 and 0.018,
respectively). Similarly, IMR was associated with excess mortality with
NYHA class I to II (RR=2.19,
P=0.007) or III to IV (RR=2.15,
P=0.005) even after adjustment
for age, sex, and EF (both P<0.04).
Impact of IMR on Cardiac Mortality
Of 118 deaths, 91 (77%) were cardiovascular. Patients
with IMR experienced higher cardiac mortality than those without MR
(50±6% versus 30±5% at 5 years,
P0.001; RR [95% CI], 2.30
[1.47 to 3.72]).
In multivariate analysis, independent predictors of cardiac death were age (P<0.001), EF (P=0.004), NYHA class III to IV (P=0.021), diabetes (P=0.048), chest pain at presentation (P=0.050), atrial fibrillation (P=0.019), and 1/creatinine (P=0.085). IMR independently influenced cardiac mortality (adjusted RR [95% CI], 1.83 [1.13 to 2.96], P=0.014). When EF was decreased in IMR by 4%, 8%, or 10%, the adjusted RRs associated with IMR presence were, respectively, 1.76, 1.60, and 1.53.
Cardiac death at 5 years was 52±7% with RVol 30 mL and
46±9% with RVol <30 mL
(P<0.001). Adjusted RRs (95%
CIs) of cardiac death compared with patients without MR remained
similar to those calculated for total mortality: 1.58 (0.89 to 2.86),
P=0.13 for RVol <30 mL and
2.01 (1.19 to 3.38), P=0.009
for RVol 30 mL, respectively. At 5 years, cardiac death with ERO <20
mm2 and 20 mm2
was 43±9% and 63±10%, respectively
(P<0.001). The adjusted RR
(95% CI) of cardiac death compared with patients without MR was 1.56
(0.88 to 2.76) for ERO <20 mm2
(P=0.13) and 2.38 (1.31 to
4.31) for ERO 20 mm2
(P=0.004).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The present study showed that compared with patients of similar age, sex, history of MI, and EF, patients with ischemic MR, that is, MR due to a previous MI (>16 days), have a marked excess mortality due to excess cardiac mortality. This excess mortality was observed independently of all baseline characteristics and in all subgroups. A higher degree of quantitatively defined IMR, in particular, a larger ERO of IMR (
20 mm2),
is directly and independently associated with a higher mortality risk.
These data underscore the importance of IMR presence and of
quantitatively defined higher IMR degree as markers of poor outcome in
the post-MI chronic phase. These data also underscore the importance of
Doppler echocardiography in defining IMR presence and in quantifying
its degree for risk stratification of post-MI patients.
MI and MR
IMR is defined as MR due to coronary disease (and not
fortuitously associated with it). IMR is caused by ischemic myocardial
alterations despite normal mitral leaflets and chordae. The hyperacute
papillary muscle rupture in acute MI is well defined, requiring urgent
surgery.17 Conversely,
prognosis and management of IMR not due to papillary muscle rupture are
poorly defined. The mechanisms leading to development of IMR are
debated,18 but recent
reports suggest that LV remodeling and papillary muscle displacement
may play an important
role.19 20
Irrespective of mechanistic issues, the presence of IMR in
acute1 2 3
or recent (16 days)5 phases
of MI is associated with adverse prognosis.
Conversely, prognosis of MR in the post-MI chronic phase (>16 days)5 has not been specifically analyzed. Pioneering series from the SAVE5 and Duke databases4 suggested that IMR may be associated with poor outcome. However, these series included patients in acute or recent post-MI phases.4 5 Furthermore, uncertainties concerning the effect of IMR on survival stemmed from exclusion of severe MR5 or from the combination of MR and clinical severity scoring.4 Therefore, we analyzed the specific prognostic impact of MR in the chronic post-MI phase (>16 days) using routine practice Doppler for defining IMR to avoid selection bias4 5 and to characterize valvular anatomy. To avoid disputable adjustment,4 we matched patients with and without IMR for age, sex, history of MI, and EF. To avoid overestimation by color flow imaging,7 quantitative methods used extensively in our laboratory9 10 16 measured IMR degree.
The present study demonstrated that in the chronic post-MI phase, IMR presence is associated with excess mortality of cardiac cause. Although patients without MR exhibited notable mortality because of their history of MI with LV dysfunction,21 those with IMR and identical EF displayed marked excess mortality. Even when the potential artificial EF increase in IMR due to regurgitation was taken into account, IMR presence remained an independent marker of marked excess mortality. Importantly, IMR is associated with more severe symptoms and pulmonary hypertension.22 However, IMR remains an independent predictor of excess mortality in patients with and without baseline symptoms and with adjustment for all baseline predictors of survival,4 which is confirmed by the independent association of IMR with cardiac mortality. Importantly, IMR is not a mere marker, but rather its detrimental consequences increase with its degree.
Degree of IMR and Outcome
Higher RVol and ERO are independently predictive of
greater mortality after diagnosis. With ERO 20
mm2, risk is considerable (adjusted RR 2.23
versus patients without MR). The link between higher IMR degree and
greater mortality is independent of EF and involves several mechanisms.
IMR is a major determinant of filling
pressures22 and can directly
cause heart failure, independently of but potentiated by the frequent
association of restrictive LV
filling23 and its related
worse hemodynamics22 and
outcome.23 Also, volume
overload of IMR stimulates LV
remodeling,24 leading to
long-term mortality after MI.25
These mechanistic rationales support the present results with larger degrees of IMR associated with worse survival independently of background EF decrease. The seminal, provocative observation of SAVE5 that even mild IMR is associated with poor outcome was limited by exclusion of severe MR. The present observation is the first to report that the quantification of IMR, in particular as ERO area, has major consequences for outcome. Of note, ERO is a stronger prognostic indicator than RVol. A large ERO can lead to large regurgitant kinetic energy (large RVol) but also to potential energy, with low RVol but high LA pressure and V wave. The latter hemodynamic situation may be deceiving without quantitative measurements, simulating a mild regurgitation but nevertheless having severe outcome consequences.22
Of note, ERO 20 mm2 is
associated with marked excess mortality in IMR, whereas in organic MR,
ERO 40 mm2 is considered
severe,12 probably owing to
different LV and LA function and compliance. Nevertheless, ERO 20
mm2 defines IMR with severe consequences
consistently with previous
observations,22 allowing
risk stratification of patients with previous MI.
Clinical Implications
The present data underscore the importance of detecting
and quantifying (by Doppler echocardiography) IMR after MI. The
independent link between RVol and ERO measured in routine practice and
subsequent survival emphasizes the clinical relevance of these
indices.
A high degree of IMR is associated with considerable excess
mortality, suggesting that aggressive therapeutic interventions should
be considered. The decrease in IMR caused by
vasodilators26 is an
important part of their clinical
effect.5 27 The
roles of isolated
revascularization28 29
or associated mitral
repair30 have not been well
defined. Because of the considerable excess mortality observed with ERO
20 mm2, an appropriately sized clinical
trial is warranted to determine whether mitral repair may improve the
long-term outcome of these patients.
Limitations of the Study
MR after MI cannot be randomized, and baseline
differences are expected between patients with and without
IMR,4 but matching ensures
comparability for major variables such as age, sex, and EF. Adjustment
for other variables (eg, symptoms or atrial fibrillation) or analysis
of subgroups defined with these variables confirmed that IMR was an
independent determinant of excess mortality. Also, no difference in
treatment with aspirin, ß-blockers, or statins was noted (all
P>0.20), and patients with IMR
received ACE inhibitors more often than those without IMR (71% versus
59%, P=0.035). Therefore, the
excess mortality of IMR cannot be attributed to medical therapy.
Furthermore, mortality was related to IMR degree even when analysis was
restricted to patients with IMR
(P<0.001), and in patients
without MR (39% at 5 years), the mortality rate was similar to
previous
studies,1 2 in
particular SAVE,5 showing
that the control group did not affect present study
results.
The association of IMR with excess mortality may reflect more severe LV alterations than occur in those without MR. Such issues will be addressed when a clinical trial demonstrates that surgical correction of IMR improves survival. However, IMR was predictive of overall and cardiac mortality in all subgroups and independently of EF, even after EF was decreased by 4%, 8%, or even 10% in patients with IMR, suggesting that assessment of survival improvement provided by treatment of IMR is necessary.
Conclusions
The present study demonstrated that in the post-MI
chronic phase, independently of all baseline characteristics, the
presence and degree of IMR, quantified by Doppler echocardiography,
both have major prognostic implications. The excess mortality, which
was considerable for ERO 20 mm2, suggests
that quantification of MR in the post-MI chronic phase is essential for
risk stratification. Furthermore, the high risk associated with IMR
suggests that such patients should be managed actively and that all
therapeutic options of medical and surgical treatment should be
considered
promptly.
|
Acknowledgments |
|---|
Dr Grigioni was supported by the Mayo Foundation.
|
Footnotes |
|---|
Reprint requests to Dr Maurice Enriquez-Sarano, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Received August 15, 2000; revision received December 12, 2000; accepted December 15, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Barzilai B, Gessler C Jr, Perez JE, et al. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol. 1988;61:220–223.[Medline] [Order article via Infotrieve]
2. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction: incidence, clinical detection, and prognostic implications: TIMI Study Group. Ann Intern Med. 1992;117:10–17.
3. Tcheng JE, Jackman JD Jr, Nelson CL, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med. 1992;117:18–24.
4. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation: implications for future management. Circulation. 1988;78:I-51–I-59.
5.
Lamas GA, Mitchell
GF, Flaker GC, et al. Clinical significance of mitral regurgitation
after acute myocardial infarction: Survival And Ventricular Enlargement
Investigators. Circulation. 1997;96:827–833.
6. Desjardins VA, Enriquez-Sarano M, Tajik AJ, et al. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med. 1996;100:149–156.[Medline] [Order article via Infotrieve]
7. McCully RB, Enriquez-Sarano M, Tajik AJ, et al. Overestimation of severity of ischemic/functional mitral regurgitation by color Doppler jet area. Am J Cardiol. 1994;74:790–793.[Medline] [Order article via Infotrieve]
8. Rokey R, Sterling LL, Zoghbi WA, et al. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol. 1986;7:1273–1278.[Abstract]
9.
Enriquez-Sarano M,
Bailey KR, Seward JB, et al. Quantitative Doppler assessment of
valvular regurgitation.
Circulation. 1993;87:841–848.
10. Enriquez-Sarano M, Miller FA Jr, Hayes SN, et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995;25:703–709.[Abstract]
11.
Vandervoort PM,
Rivera JM, Mele D, et al. Application of color Doppler flow mapping to
calculate effective regurgitant orifice area: an in vitro study and
initial clinical observations.
Circulation. 1993;88:1150–1156.
12.
Dujardin KS,
Enriquez-Sarano M, Bailey KR, et al. Grading of mitral regurgitation by
quantitative Doppler echocardiography: calibration by left ventricular
angiography in routine clinical practice.
Circulation. 1997;96:3409–3415.
13. Amico AF, Lichtenberg GS, Reisner SA, et al. Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J. 1989;118:1259–1265.[Medline] [Order article via Infotrieve]
14.
Quinones MA,
Waggoner AD, Reduto LA, et al. A new, simplified and accurate method
for determining ejection fraction with two-dimensional
echocardiography. Circulation. 1981;64:744–753.
15.
Ling LH,
Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral
regurgitation due to flail leaflet. N
Engl J Med. 1996;335:1417–1423.
16. Enriquez-Sarano M, Seward JB, Bailey KR, et al. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol. 1994;23:443–451.[Abstract]
17. Kishon Y, Oh JK, Schaff HV, et al. Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients. Mayo Clin Proc. 1992;67:1023–1030.[Medline] [Order article via Infotrieve]
18. Kono T, Sabbah HN, Rosman H, et al. Mechanism of functional mitral regurgitation during acute myocardial ischemia. J Am Coll Cardiol. 1992;19:1101–1105.[Abstract]
19.
Otsuji Y,
Handschumacher MD, Schwammenthal E, et al. Insights from
three-dimensional echocardiography into the mechanism of functional
mitral regurgitation: direct in vivo demonstration of altered leaflet
tethering geometry.
Circulation. 1997;96:1999–2008.
20.
Yiu SF,
Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of
functional mitral regurgitation in patients with systolic left
ventricular dysfunction: a quantitative clinical study.
Circulation. 2000;102:1400–1406.
21. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med. 1992;327:669–677.[Abstract]
22. Enriquez-Sarano M, Rossi A, Seward JB, et al. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol. 1997;29:153–159.[Abstract]
23.
Rihal CS,
Nishimura RA, Hatle LK, et al. Systolic and diastolic dysfunction in
patients with clinical diagnosis of dilated cardiomyopathy: relation to
symptoms and prognosis.
Circulation. 1994;90:2772–2779.
24. Pouleur HG, Konstam MA, Udelson JE, et al. Changes in ventricular volume, wall thickness and wall stress during progression of left ventricular dysfunction: the SOLVD Investigators. J Am Coll Cardiol. 1993;22:43A–48A.
25.
St. John Sutton
M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional
echocardiographic measurements are major predictors of adverse
cardiovascular events after acute myocardial infarction: the protective
effects of captopril.
Circulation. 1994;89:68–75.
26. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987;60:654–658.[Medline] [Order article via Infotrieve]
27. Evangelista-Masip A, Bruguera-Cortada J, Serrat-Serradell R, et al. Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:373–376.[Medline] [Order article via Infotrieve]
28. Arcidi JM Jr, Hebeler RF, Craver JM, et al. Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone. J Thorac Cardiovasc Surg. 1988;95:951–959.[Abstract]
29. Czer LS, Maurer G, Bolger AF, et al. Revascularization alone or combined with suture annuloplasty for ischemic mitral regurgitation: evaluation by color Doppler echocardiography. Tex Heart Inst J. 1996;23:270–278.[Medline] [Order article via Infotrieve]
30.
Bolling SF, Deeb
GM, Brunsting LA, et al. Early outcome of mitral valve reconstruction
in patients with end-stage cardiomyopathy.
J Thorac Cardiovasc Surg. 1995;109:676–682.
This article has been cited by other articles:
 |
|
 |
|
  B. de Varennes, R. Chaturvedi, S. Sidhu, A. V. Cote, W. L. P. Shan, C. Goyer, R. Hatzakorzian, J. Buithieu, and A. Sniderman Initial Results of Posterior Leaflet Extension for Severe Type IIIb Ischemic Mitral Regurgitation Circulation, June 2, 2009; 119(21): 2837 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Silberman, M. W. Klutstein, T. Sabag, A. Oren, D. Fink, O. Merin, and D. Bitran Repair of Ischemic Mitral Regurgitation: Comparison Between Flexible and Rigid Annuloplasty Rings. Ann. Thorac. Surg., June 1, 2009; 87(6): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Agricola, A. Ielasi, M. Oppizzi, P. Faggiano, L. Ferri, A. Calabrese, E. Vizzardi, O. Alfieri, and A. Margonato Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction Eur J Heart Fail, June 1, 2009; 11(6): 581 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Delgado, L. F. Tops, J. D. Schuijf, A. de Roos, J. Brugada, M. J. Schalij, J. D. Thomas, and J. J. Bax Assessment of mitral valve anatomy and geometry with multislice computed tomography. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 556 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Mauro, A. Bivona, A. L. Iaco, M. Contini, M. Gagliardi, E. Varone, S. Gallina, and A. M. Calafiore Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 635 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Stevens, R. Farzaneh-Far, B. Na, M. A. Whooley, and N. B. Schiller Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Quinones Role of echocardiography in predicting onset of heart failure in patients with stable coronary artery disease: is the whole greater than the sum of its parts? J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 21 - 23. [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Armen, R. Vandse, J. A. Crestanello, S. V. Raman, K. M. Bickle, and N. S. Nathan Mechanisms of valve competency after mitral valve annuloplasty for ischaemic mitral regurgitation using the Geoform ring: insights from three-dimensional echocardiography Eur J Echocardiogr, January 1, 2009; 10(1): 74 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Donal, C. De Place, G. Kervio, F. Bauer, R. Gervais, C. Leclercq, P. Mabo, and J.-C. Daubert Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony Eur J Echocardiogr, January 1, 2009; 10(1): 133 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Klein, J. J. Bax, L. J. Shaw, H. H.H. Feringa, M. I.M. Versteegh, R. A.E. Dion, and R. J.M. Klautz Early and late outcome of left ventricular reconstruction surgery in ischemic heart disease Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1149 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sorajja, R. A. Nishimura, J. Thompson, and K. Zehr A Novel Method of Percutaneous Mitral Valve Repair for Ischemic Mitral Regurgitation J. Am. Coll. Cardiol. Intv., December 1, 2008; 1(6): 663 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Z Naqvi, A M Rafique, C Swerdlow, S Verma, R J Siegel, K Tolstrup, W Kerwin, J Goodman, D Gallik, E Gang, et al. Predictors of reduction in mitral regurgitation in patients undergoing cardiac resynchronisation treatment Heart, December 1, 2008; 94(12): 1580 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. M. Westenberg, S. D. Roes, N. Ajmone Marsan, N. M. J. Binnendijk, J. Doornbos, J. J. Bax, J. H. C. Reiber, A. de Roos, and R. J. van der Geest Mitral Valve and Tricuspid Valve Blood Flow: Accurate Quantification with 3D Velocity-encoded MR Imaging with Retrospective Valve Tracking Radiology, December 1, 2008; 249(3): 792 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D'Ancona, D. Biondo, G. Mamone, G. Marrone, F. Pirone, G. Santise, S. Sciacca, and M. Pilato Ischemic mitral valve regurgitation in patients with depressed ventricular function: cardiac geometrical and myocardial perfusion evaluation with magnetic resonance imaging Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 964 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Masuyama, A. Marui, T. Shimamoto, M. Nonaka, M. Tsukiji, N. Watanabe, T. Ikeda, K. Yoshida, and M. Komeda Chordal translocation for ischemic mitral regurgitation may ameliorate tethering of the posterior and anterior mitral leaflets. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Siminiak and J. Lipiecki Trans-Coronary-Venous Interventions Circ Cardiovasc Intervent, October 1, 2008; 1(2): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hung, J. Solis, J. L. Guerrero, G. J.C. Braithwaite, O. K. Muratoglu, M. Chaput, L. Fernandez-Friera, M. D. Handschumacher, V. J. Wedeen, S. Houser, et al. A Novel Approach for Reducing Ischemic Mitral Regurgitation by Injection of a Polymer to Reverse Remodel and Reposition Displaced Papillary Muscles Circulation, September 30, 2008; 118(14_suppl_1): S263 - S269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]
|
|
|
|
|
|
R. B. Prucz, E. S. Weiss, N. D. Patel, L. U. Nwakanma, A. S. Shah, and J. V. Conte The Impact of Surgical Ventricular Restoration on Mitral Valve Regurgitation Ann. Thorac. Surg., September 1, 2008; 86(3): 726 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gelsomino, R. Lorusso, C. Rostagno, S. Caciolli, G. Bille, G. De Cicco, S. Romagnoli, C. Porciani, P. Stefano, and G. F. Gensini Prognostic value of Doppler-derived mitral deceleration time on left ventricular reverse remodelling after undersized mitral annuloplasty Eur J Echocardiogr, September 1, 2008; 9(5): 631 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Buck, B. Plicht, P. Kahlert, I. M. Schenk, P. Hunold, and R. Erbel Effect of Dynamic Flow Rate and Orifice Area on Mitral Regurgitant Stroke Volume Quantification Using the Proximal Isovelocity Surface Area Method J. Am. Coll. Cardiol., August 26, 2008; 52(9): 767 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chaput, M. D. Handschumacher, F. Tournoux, L. Hua, J. L. Guerrero, G. J. Vlahakes, and R. A. Levine Mitral Leaflet Adaptation to Ventricular Remodeling: Occurrence and Adequacy in Patients With Functional Mitral Regurgitation Circulation, August 19, 2008; 118(8): 845 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Calafiore, V. Mazzei, A. L. Iaco, M. Contini, A. Bivona, M. Gagliardi, P. Bosco, S. Gallina, and M. Di Mauro Impact of Ischemic Mitral Regurgitation on Long-Term Outcome of Patients With Ejection Fraction Above 0.30 Undergoing First Isolated Myocardial Revascularization Ann. Thorac. Surg., August 1, 2008; 86(2): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gelsomino, R. Lorusso, S. Caciolli, I. Capecchi, C. Rostagno, M. Chioccioli, G. De Cicco, G. Bille, P. Stefano, and G. F. Gensini Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 507 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lentini, P. Mure, F. Tancredi, and R. Gaeta eComment: Insights in the reshaping of the ischemic ventricle Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 707 - 708. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Calafiore, A. L. Iaco, M. Contini, A. Bivona, E. Varone, P. Greco, and S. Scandura Mitral Valve Repair for Ischemic Mitral Regurgitation Angiology, August 1, 2008; 59(2_suppl): 89S - 92S. [Abstract] [PDF]
|
|
|
|
 |
|
 T. H. Marwick and M. Schwaiger The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 1: Tasks and Tools Circ Cardiovasc Imaging, July 1, 2008; 1(1): 58 - 69. [Full Text] [PDF]
|
|
|
|
|
|
F. L. Dini, P. Fontanive, E. Panicucci, D. Andreini, P. Chella, and S. M. De Tommasi Prognostic significance of tricuspid annular motion and plasma NT-proBNP in patients with heart failure and moderate-to-severe functional mitral regurgitation Eur J Heart Fail, June 1, 2008; 10(6): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. St John Sutton Quest for Diastolic Prognostic Indicators of Clinical Outcome After Acute Myocardial Infarction Circulation, May 20, 2008; 117(20): 2570 - 2572. [Full Text] [PDF]
|
|
|
|
|
|
T. D. Crabtree, M. S. Bailey, M. R. Moon, N. Munfakh, M. K. Pasque, J. S. Lawton, N. Moazami, K. A. Aubuchon, A. S. Al-Dadah, and R. J. Damiano Jr Recurrent Mitral Regurgitation and Risk Factors for Early and Late Mortality After Mitral Valve Repair for Functional Ischemic Mitral Regurgitation Ann. Thorac. Surg., May 1, 2008; 85(5): 1537 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-M Song, M-J Kim, Y-J Kim, S-H Kang, J-J Kim, D-H Kang, and J-K Song Three-dimensional characteristics of functional mitral regurgitation in patients with severe left ventricular dysfunction: a real-time three-dimensional colour Doppler echocardiography study Heart, May 1, 2008; 94(5): 590 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Magne, M. Senechal, P. Mathieu, J. G. Dumesnil, F. Dagenais, and P. Pibarot Restrictive Annuloplasty for Ischemic Mitral Regurgitation May Induce Functional Mitral Stenosis J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1692 - 1701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Marwick Restrictive Annuloplasty for Ischemic Mitral Regurgitation: Too Little or Too Much? J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1702 - 1703. [Full Text] [PDF]
|
|
|
|
|
|
S. Gelsomino, R. Lorusso, I. Capecchi, C. Rostagno, S. Romagnoli, G. Bille, G. De Cicco, C. Tetta, P. Stefano, and G. F. Gensini Left Ventricular Reverse Remodeling After Undersized Mitral Ring Annuloplasty in Patients With Ischemic Regurgitation Ann. Thorac. Surg., April 1, 2008; 85(4): 1319 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lancellotti, B. Cosyns, and L. A. Pierard Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure Europace, April 1, 2008; 10(4): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ypenburg, P. Lancellotti, L. F. Tops, E. Boersma, G. B. Bleeker, E. R. Holman, J. D. Thomas, M. J. Schalij, L. A. Pierard, and J. J. Bax Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy Eur. Heart J., March 2, 2008; 29(6): 757 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. De Bonis, E. Lapenna, A. Verzini, G. La Canna, A. Grimaldi, L. Torracca, F. Maisano, and O. Alfieri Recurrence of Mitral Regurgitation Parallels the Absence of Left Ventricular Reverse Remodeling After Mitral Repair in Advanced Dilated Cardiomyopathy Ann. Thorac. Surg., March 1, 2008; 85(3): 932 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Agricola, M. Oppizzi, M. Pisani, A. Meris, F. Maisano, and A. Margonato Ischemic mitral regurgitation: mechanisms and echocardiographic classification Eur J Echocardiogr, March 1, 2008; 9(2): 207 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Braun, N. R. van de Veire, R. J.M. Klautz, M. I.M. Versteegh, E. R. Holman, J. J.M. Westenberg, E. Boersma, E. E. van der Wall, J. J. Bax, and R. A.E. Dion Restrictive Mitral Annuloplasty Cures Ischemic Mitral Regurgitation and Heart Failure Ann. Thorac. Surg., February 1, 2008; 85(2): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Beeri, C. Yosefy, J. L. Guerrero, F. Nesta, S. Abedat, M. Chaput, F. del Monte, M. D. Handschumacher, R. Stroud, S. Sullivan, et al. Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 476 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Enriquez-Sarano, D. F. Loulmet, and D. Burkhoff The conundrum of functional mitral regurgitation in chronic heart failure. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 487 - 489. [Full Text] [PDF]
|
|
|
|
|
|
S. Gelsomino, R. Lorusso, G. De Cicco, I. Capecchi, C. Rostagno, S. Caciolli, S. Romagnoli, U. Da Broi, P. Stefano, and G. F. Gensini Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation Eur. Heart J., January 2, 2008; 29(2): 231 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kolh Surgical correction of ischaemic mitral regurgitation still a long way to go Eur. Heart J., January 2, 2008; 29(2): 147 - 149. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Enriquez-Sarano, V. T. Nkomo, and H. Michelena Principles and Practice of Echocardiography in Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 315 - 348. [Full Text]
|
|
|
|
|
|
W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker Ischemic Mitral Regurgitation Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802. [Full Text]
|
|
|
|
|
|
J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text]
|
|
|
|
|
|
P. Lancellotti, E. Donal, B. Cosyns, G. Van Camp, J.-L. Monin, E. Brochet, A. Berrebi, P. Pibarot, C. Chauvel, C. Hassager, et al. Effects of surgery on ischaemic mitral regurgitation: a prospective multicentre registry (SIMRAM registry) Eur J Echocardiogr, January 1, 2008; 9(1): 26 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Donato, S. Castelvecchio, J. Brankovic, C. Santambrogio, V. Montericcio, and L. Menicanti Effectiveness of surgical ventricular restoration in patients with dilated ischemic cardiomyopathy and unrepaired mild mitral regurgitation. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1548 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Perez de Isla, J. Zamorano, M. Quezada, C. Almeria, J. L. Rodrigo, V. Serra, J. C. Garcia Rubira, A. F. Ortiz, and C. Macaya Functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome: contribution to congestive heart failure Eur. Heart J., December 1, 2007; 28(23): 2866 - 2872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ypenburg, P. Lancellotti, L. F. Tops, G. B. Bleeker, E. R. Holman, L. A. Pierard, M. J. Schalij, and J. J. Bax Acute Effects of Initiation and Withdrawal of Cardiac Resynchronization Therapy on Papillary Muscle Dyssynchrony and Mitral Regurgitation J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2071 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Ryan, B. M. Jackson, L. M. Parish, H. Sakamoto, T. J. Plappert, M. St. John-Sutton, J. H. Gorman III, and R. C. Gorman Mitral Valve Tenting Index for Assessment of Subvalvular Remodeling Ann. Thorac. Surg., October 1, 2007; 84(4): 1243 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hung, M. Chaput, J. L. Guerrero, M. D. Handschumacher, L. Papakostas, S. Sullivan, J. Solis, and R. A. Levine Persistent Reduction of Ischemic Mitral Regurgitation by Papillary Muscle Repositioning: Structural Stabilization of the Papillary Muscle Ventricular Wall Complex Circulation, September 11, 2007; 116(11_suppl): I-259 - I-263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Beeri, C. Yosefy, J. L. Guerrero, S. Abedat, M. D. Handschumacher, R. E. Stroud, S. Sullivan, M. Chaput, D. Gilon, G. J. Vlahakes, et al. Early Repair of Moderate Ischemic Mitral Regurgitation Reverses Left Ventricular Remodeling: A Functional and Molecular Study Circulation, September 11, 2007; 116(11_suppl): I-288 - I-293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Roshanali, M. H. Mandegar, M. A. Yousefnia, H. Rayatzadeh, and F. Alaeddini A Prospective Study of Predicting Factors in Ischemic Mitral Regurgitation Recurrence After Ring Annuloplasty Ann. Thorac. Surg., September 1, 2007; 84(3): 745 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D'Ancona, G. Mamone, G. Marrone, F. Pirone, G. Santise, S. Sciacca, and M. Pilato Ischemic mitral valve regurgitation: the new challenge for magnetic resonance imaging Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 475 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Menicanti, S. Castelvecchio, M. Ranucci, A. Frigiola, C. Santambrogio, C. de Vincentiis, J. Brankovic, and M. Di Donato Surgical therapy for ischemic heart failure: Single-center experience with surgical anterior ventricular restoration J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mihaljevic, B.-K. Lam, J. Rajeswaran, M. Takagaki, M. S. Lauer, A. M. Gillinov, E. H. Blackstone, and B. W. Lytle Impact of Mitral Valve Annuloplasty Combined With Revascularization in Patients With Functional Ischemic Mitral Regurgitation J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2191 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Borger, P. M. Murphy, A. Alam, S. Fazel, M. Maganti, S. Armstrong, V. Rao, and T. E. David Initial results of the chordal-cutting operation for ischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1483 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A Pierard and P. Lancellotti Stress testing in valve disease Heart, June 1, 2007; 93(6): 766 - 772. [Full Text] [PDF]
|
|
|
|
|
|
J. Kwan, M. A. Gillinov, J. D. Thomas, and T. Shiota Geometric predictor of significant mitral regurgitation in patients with severe ischemic cardiomyopathy, undergoing Dor procedure: A real-time 3D echocardiographic study Eur J Echocardiogr, June 1, 2007; 8(3): 195 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ryan, B. Jackson, L. Parish, H. Sakamoto, T. Plappert, M. St. J. Sutton, J. Gorman III, and R. Gorman Quantification and localization of mitral valve tenting in ischemic mitral regurgitation using real-time three-dimensional echocardiography Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 839 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sartipy, A. Albage, E. Mattsson, and D. Lindblom Edge-to-Edge Mitral Repair Without Annuloplasty in Combination With Surgical Ventricular Restoration Ann. Thorac. Surg., April 1, 2007; 83(4): 1303 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukuoka, M. Nonaka, S. Masuyama, T. Shimamoto, K. Tambara, H. Yoshida, T. Ikeda, and M. Komeda Chordal "translocation" for functional mitral regurgitation with severe valve tenting: An effort to preserve left ventricular structure and function J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1004 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Magne, P. Pibarot, F. Dagenais, Z. Hachicha, J. G. Dumesnil, and M. Senechal Preoperative Posterior Leaflet Angle Accurately Predicts Outcome After Restrictive Mitral Valve Annuloplasty for Ischemic Mitral Regurgitation Circulation, February 13, 2007; 115(6): 782 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pocar, A. Moneta, A. Grossi, and F. Donatelli Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow-Up Ann. Thorac. Surg., February 1, 2007; 83(2): 468 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Aronson, N. Goldsher, R. Zukermann, M. Kapeliovich, J. Lessick, D. Mutlak, S. Dabbah, W. Markiewicz, R. Beyar, H. Hammerman, et al. Ischemic Mitral Regurgitation and Risk of Heart Failure After Myocardial Infarction Arch Intern Med, November 27, 2006; 166(21): 2362 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Perez de Isla, J. Zamorano, M. Quezada, C. Almeria, J. L. Rodrigo, V. Serra, J. C. Garcia Rubira, A. F. Ortiz, and C. Macaya Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome Eur. Heart J., November 2, 2006; 27(22): 2655 - 2660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A.F. Tulner, J. J. Bax, G. B. Bleeker, P. Steendijk, R. J.M. Klautz, E. R. Holman, M. J. Schalij, R. A.E. Dion, and E. E. van der Wall Beneficial Hemodynamic and Clinical Effects of Surgical Ventricular Restoration in Patients With Ischemic Dilated Cardiomyopathy Ann. Thorac. Surg., November 1, 2006; 82(5): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J J Bax and D Poldermans Mitral regurgitation and left ventricular dyssynchrony: implications for treatment Heart, October 1, 2006; 92(10): 1363 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure Circulation, September 12, 2006; 114(11): 1202 - 1213. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF]
|
|
|
|
|
|
D. Maselli, F. Guarracino, F. Chiaramonti, F. Mangia, G. Borelli, and G. Minzioni Percutaneous Mitral Annuloplasty: An Anatomic Study of Human Coronary Sinus and Its Relation With Mitral Valve Annulus and Coronary Arteries Circulation, August 1, 2006; 114(5): 377 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Detaint, T. M. Sundt, V. T. Nkomo, C. G. Scott, A. J. Tajik, H. V. Schaff, and M. Enriquez-Sarano Surgical Correction of Mitral Regurgitation in the Elderly: Outcomes and Recent Improvements Circulation, July 25, 2006; 114(4): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Spoor, A. Geltz, and S. F. Bolling Flexible Versus Nonflexible Mitral Valve Rings for Congestive Heart Failure: Differential Durability of Repair Circulation, July 4, 2006; 114(1_suppl): I-67 - I-71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-H. Kang, M.-J. Kim, S.-J. Kang, J.-M. Song, H. Song, M.-K. Hong, K.-J. Choi, J.-K. Song, and J.-W. Lee Mitral Valve Repair Versus Revascularization Alone in the Treatment of Ischemic Mitral Regurgitation Circulation, July 4, 2006; 114(1_suppl): I-499 - I-503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Daimon, S. Fukuda, D. H. Adams, P. M. McCarthy, A. M. Gillinov, A. Carpentier, F. Filsoufi, V. M. Abascal, V. H. Rigolin, S. Salzberg, et al. Mitral Valve Repair With Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring for Ischemic Mitral Regurgitation: Early Echocardiographic Results From a Multi-Center Study Circulation, July 4, 2006; 114(1_suppl): I-588 - I-593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Mauro, G. Di Giammarco, G. Vitolla, M. Contini, A. L. Iaco, A. Bivona, L. Weltert, and A. M. Calafiore Impact of No-to-Moderate Mitral Regurgitation on Late Results After Isolated Coronary Artery Bypass Grafting in Patients With Ischemic Cardiomyopathy Ann. Thorac. Surg., June 1, 2006; 81(6): 2128 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Messas, A. Bel, M. C. Morichetti, C. Carrion, M. D. Handschumacher, S. Peyrard, J. T. Vilquin, M. Desnos, P. Bruneval, A. Carpentier, et al. Autologous Myoblast Transplantation for Chronic Ischemic Mitral Regurgitation J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2086 - 2093. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||